PRESS BOX
MORE IR NEWS
Release according to art. 93 section 2 BörseG
Managers' transactions announcement according to article 19 MAR
Managers' transactions announcement according to article 19 MAR
Medigene collaborates with RXi Pharmaceuticals to further sharpen its therapeutic T cells
Release of capital market information
Managers' transactions announcement according to article 19 MAR
Managers' transactions announcement according to article 19 MAR
 
ANNOUNCEMENT OF 10.04.2017 04:42 PM
Meldung drucken Artikel weiterleiten
pta20171004036
Voting rights according to article 21-26 WpHG
Pressefach Pressefach

Dr. Hönle AG: Release according to Article 26, Section 1 of the WpHG

Voting Rights Announcement according to §§ 21 ff WpHG

Gräfelfing/München (pta036/04.10.2017/16:42) - Release of Voting Rights Announcement

Notification of Major Holdings

1. Details of issuer:
Dr. Hönle AG, Lochhamer Schlag 1, 82166 Gräfelfing/München, Germany

2. Reason for notification:
Acquisition / disposal of shares with voting rights

3. Details of person subject to the notification obligation
Name: Dr. Hans-Joachim Vits, 23.11.1935

4. Names of shareholder(s) holding directly 3% or more voting rights, if different from 3


5. Date on which threshold was crossed or reached
25.04.2016

6. Total positions

% of voting rights attached to shares (total of 7.a.) % of voting rights through instruments (total of 7.b.1 + 7.b.2) total of both in % (7.a. + 7.b.) total number of voting rights of issuer
Resulting situation 4.63 0.00 4.63 5,512,930
Previous notification 6,33

7. Notified details of the resulting situation

a. Voting rights attached to shares (Sec.s 21, 22 WpHG)

ISIN absolute direct (§ 21 WpHG) absolute indirect (§ 22 WpHG) in % direct (§ 21 WpHG) in % indirect (§ 22 WpHG)
DE0005157101 255,301 0 4.63 0.00
Total: 255,301 4.63

b.1. Instruments according to Sec. 25 Abs. 1 Nr. 1 WpHG

Type of instrument Maturity / Expiration Exercise or conversion period Voting Rights Absolute Voting Rights in %
Total:

b.2 Instruments according to Sec. 25 Abs. 1 Nr. 2 WpHG

Type of instrument Maturity / Expiration Exercise or conversion period Cash or physical transaction Voting Rights Absolute Voting Rights in %
Total:

8. Information in relation to the person subject to the notification obligation

Person subject to the notification obligation is not controlled and does itself not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer (1.).

Name % of voting rights if 3% or higher % of voting rights through instruments if 5% or higher Total of both if 5% or higher

9. In case of proxy voting according to § 22 Abs. 3 WpHG

Date of general meeting: N/A

10. Other useful information
Donation to grandchildren

(end)

emitter: Dr. Hönle AG
Lochhamer Schlag 1
82166 Gräfelfing/München
Germany
contact person: Peter Weinert
phone: +49 89 85608-173
e-mail:
website: www.hoenle.de
ISIN(s): DE0005157101 (share)
stock exchanges: regulated market in Frankfurt; free market in Dusseldorf, free market in Hamburg, free market in Hannover, free market in Munich, free market in Stuttgart; open market in Berlin, Tradegate
Dr. Hönle AG